LinkLight™ U2-OS DRD2 / β-arrestin Cell Line
LinkLight™ U2-OS DRD2 / β-arrestin Cell Line is a stable monoclonal cell line in U2-OS cells, targeting Human DRD2 pathway via b-arrestin. The proprietary LinkLight™ technology uses a standard Luciferase Assay as the detection method. Bon Opus Cat. #BC050016
BackgroundDRD2 acts as a receptor that inhibits adenylyl cyclase activity, and refers to the D2 subtype of the dopamine receptor. Missense mutation in this gene can cause myoclonus dystonia. Other mutations are associated with schizophrenia.
PackagingShip on Dry Ice